Publications of Biava

Publications of Biava

1) Biava, P.M.; Fiorito, A.; Negro, C,; Mariani, M. Effect of treatment with embryonic and uterine tissue homogenates on Lewis lung carcinoma development. Cancer Letter,1988, 41, 265-270.

2) Biava, P.M.; Carluccio, A. Activation of anti-oncogene p53 produced by embryonic extracts in vitro tumor cells. J. Tumor Marker Oncol., 1977, 12, 9-15.

3) Biava P.M Complexity and Cancer Leadership Medica, xv, 1, 1999

4) Biava P.M.; Frosi A. Clinical Treatment of Hepatocarcinoma with Regulatory Network of Cell Differentiation: Results in Comparison with Historical Data. J. Tumor Marker Oncol. 1999, 2, 34.

5) Biava, P.M.; Bonsignorio, D.; Hoxa, M. Life-Protecting Factor (LPF): an anti-cancer low molecular weight fraction isolated from pregnant uterine mucosa during embryo organogenesis. J.Tumor Marker Oncol., 2000, 15(4), 223-233.

6) Biava, P.M.; Monguzzi, A.; Bonsignorio, D.; Frosi, A.; Sell,S.; Klavins, JV. Xenopus Laevis

Embryo share antigens with Zebrafish embryos and with human malignant neoplasms. J.Tumor

Marker Oncol., 2001, 16(3): 203-206.

7) Biava P. M. et al. Tumor Cells as Mutated Undifferentiated Cells, Leader for Chemist 2, 2001, 10-17

8) Biava P.M. ; Bonsignorio D.; Hoxha M. Regulation of p53 and pRb and Effects on the Proliferation Curve of Several Tumor Cell Lines after Treatment with Zebrafish Embryonic Extracts. J. Tumor Marker Oncol. 2001, 2, 104.

9) Biava, P.M.; Bonsignorio, D.; Hoxa, M. Cell proliferation curves of different human tumor lines after in vitro treatment with Zebrafish embryonic extracts. J.Tumor Marker Oncol., 2001, 16 195-202.

10) Biava P.M. et al Mother-embryo cross-talk: the anti-cancer substances produced by mother

and embryo during cell differentiation. A review of experimental data. J.Tumor Marker Oncol.,

2002, 17( 3):

11) Biava P.M.; Bonsignorio D.; Ferroni O. In vitro Effects of a Product Containing Embryonic and Decidual Extracts on the Proliferation Of Several Tumor Cell Lines. J,. Tumor MarkerOncol. 2002 3, 101.

12) Biava, P.M.; Bonsignorio, D.; Hoxa, M.; Facco, R.; Ielapi, T.; Frati, L.; Bizzarri, M. Post-traslational modification of the retinoblastoma protein (pRb) induced by in vitro administration of Zebrafish embryonic extracts on human kidney adenocarcinomacell line. J. Tumor Marker Oncol., 2002, 17(2); 59-64.

13) Biava, P.M.; Bonsignorio, D. Cancer and cell differentiation: a model to explain malignancy. J. Tumor Marker Oncol., 2002, 17(2); 47-54.

14) Biava P.M. et al. Embryonic Differentiartion Factors with Anticancer Properties: Preliminary Clinical Results in the therapy for Advanced Tumors. J. Tumor Marker Oncol. 2002 17(2); 65-69

15) Biava P. M. The Use of Stem Cells Differentiation Stage Factors in Controlling Tumor Growth. A new Model of Cancer. J. Tumor Marker Oncol. 2005. IATMO Conferebce Varese (Italy).

16) Livraghi, T.; Meloni, F.; Frosi, A.; Lazzaroni, S.; Bizzarri, M.; Frati, L.; Biava, P.M. Treatment with stem cell differentiation stage factors of intermediate-advanced hepatocellular carcinoma: an open randomized clinical trial. Oncol Res.,2005, 15 (7,8): 399-408.

17) Cucina, A.; Biava, P.M.; D’Anselmi, F.; Coluccia, P.; Conti, F.; Di Clemente, R.; Miccheli, A.; Frati, L.; Gulino, A.; Bizzarri, M. Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2). Apoptosis, 2006, 9, 1617-1628

18) Biava P.M., Frosi, A. Cancer, Cell Death and Differentiation: The role of Epigenetic Code in Tumor Growth Control. A Capri Science Conference. A Nature Conference 2007

19) Biava P. M. Cancer and Stem Cell Differentiation Stage Factors; The role of epigenetic code in tumor growth control. J. Tumor Marker Oncology. Trieste Conference 2007

20) Frosi A. ; Biava P.M., SCD Stage Factors as a Possible New Approach for Liver Transplantation Waiting List Management of HCC J. Tumor Marker Oncology. Trieste Conference 2007

21) Biava P. M. The Use of Stem Cell Differentiation Stage Factors (SCDSF) as Epigenetic Network in Tumor Growth Control. The 36 th Meeting of the International Society of Oncology and Biomarkers, ISOBM 2008. Tokyo, Tumor Biology 2008 29 (suppl. 1). 42.

22) Biava P.M. Stem Cell Differentiation Stage Factors and Their Epigenetic Influence on Tumor Growth. ISOBM International Conference Amsterdam, 2009, 90.

23) Biava P.M.; Frosi A. Treatment with Stem Cell Differentiation Stage Factors of Hepatocellular Carcinoma in Intermediate-Advanced Stage: the Results of a Clinical Trial . BIT's 3th World Cancer Conference, Singapore , June 20-25, 2010

24) Biava P.M. I fattori di differenziazione delle cellule staminali in oncologia. In Atti del Convegno Il Ruolo del Clinico nell'Era della Genetica e Delle Cellule Staminali: Attualita' e Prospettfive. Editors S. Smirne ed A. Angeletti. Universita' degli Studi di Milano. 2010. 7-13.

25) Biava P.M. Reprogramming of Normal and Cancer Stem Cells. Editorial. Curr. Pharm.Biotech. 2011, 12,(2), 145.

26) P. M. Biava1, M. Basevi2, L. Biggiero2, A. Borgonovo3, E. Borgonovo3, F. Burigana4. Cancer cell reprogramming: stem cell differentiation stage factors and an agent based model to optimize cancer treatment . Curr. Pharm. Biotech.2011 12, 2, 231-242.

27) F. D’Anselmi1,2, A. Cucina2, P.M. Biava3, S. Proiettir4, P. Coluccia2, L. Frati4, M. Bizzarri4Zebrafish stem cell differentiation stage factors suppress Bcl-xL release and enhance 5-Fu-mediated apoptosis in colon cancer cells. Curr. Pharm. Biotech.2011, 12, (2), 261-267.

28) M. Bizzarri, A. Cucina P.M. Biava S. Proietti et al. Embryonic Morphogenetic Fields Induces Phenotipic Reversion In Cancer Cells. Curr. Pharm. Biotech.2011,12,(2) 243-253.